Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Mier

Showing results (11-20 of 181) with videos related to

Pageof 19
Sort By:
Current Medicinal Chemistry|February 22, 2008
Endoradiotherapy with peptides - status and future developmentUwe Haberkorn, Michael Eisenhut, Annette Altmann, et al.
European Journal of Pharmacology|October 20, 2009
Endoradiotherapy in cancer treatment--basic concepts and future trendsFrederic Zoller, Michael Eisenhut, Uwe Haberkorn, et al.
Current Pharmaceutical Biotechnology|October 15, 2014
Rational design of CPP-based drug delivery systems: considerations from pharmacokineticsArite Mickan, Dikran Sarko, Uwe Haberkorn, et al.
Organic Letters|October 3, 2012
Acid-mediated prevention of aspartimide formation in solid phase peptide synthesisTillmann Michels, Rudolf Dölling, Uwe Haberkorn, et al.
Seminars in Nuclear Medicine|January 22, 2004
Impact of functional genomics and proteomics on radionuclide imagingUwe Haberkorn, Annette Altmann, Walter Mier, et al.
Molecules (Basel, Switzerland)|February 18, 2011
DNA libraries for the construction of phage libraries: statistical and structural requirements and synthetic methodsThomas Lindner, Harald Kolmar, Uwe Haberkorn, et al.
Drug Discovery Today|October 12, 2014
Radionuclides in drug developmentPhilipp Uhl, Gert Fricker, Uwe Haberkorn, et al.
Bioorganic & Medicinal Chemistry|June 12, 2002
Fluorescent somatostatin receptor probes for the intraoperative detection of tumor tissue with long-wavelength visible lightWalter Mier, Barbro Beijer, Keith Graham, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2009
Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: closing the gap between benefit and toxicity?Inga Buchmann, Ralf G Meyer, Walter Mier, et al.
Protein and Peptide Letters|March 10, 2007
Radiolabeled peptides and proteins in cancer therapyCarmen Wängler, Inga Buchmann, Michael Eisenhut, et al.
Pageof 19

Showing results (11-20 of 181) with videos related to

Sort By:
Pageof 19
Current Medicinal Chemistry|February 22, 2008
Endoradiotherapy with peptides - status and future developmentUwe Haberkorn, Michael Eisenhut, Annette Altmann, et al.
European Journal of Pharmacology|October 20, 2009
Endoradiotherapy in cancer treatment--basic concepts and future trendsFrederic Zoller, Michael Eisenhut, Uwe Haberkorn, et al.
Current Pharmaceutical Biotechnology|October 15, 2014
Rational design of CPP-based drug delivery systems: considerations from pharmacokineticsArite Mickan, Dikran Sarko, Uwe Haberkorn, et al.
Organic Letters|October 3, 2012
Acid-mediated prevention of aspartimide formation in solid phase peptide synthesisTillmann Michels, Rudolf Dölling, Uwe Haberkorn, et al.
Seminars in Nuclear Medicine|January 22, 2004
Impact of functional genomics and proteomics on radionuclide imagingUwe Haberkorn, Annette Altmann, Walter Mier, et al.
Molecules (Basel, Switzerland)|February 18, 2011
DNA libraries for the construction of phage libraries: statistical and structural requirements and synthetic methodsThomas Lindner, Harald Kolmar, Uwe Haberkorn, et al.
Drug Discovery Today|October 12, 2014
Radionuclides in drug developmentPhilipp Uhl, Gert Fricker, Uwe Haberkorn, et al.
Bioorganic & Medicinal Chemistry|June 12, 2002
Fluorescent somatostatin receptor probes for the intraoperative detection of tumor tissue with long-wavelength visible lightWalter Mier, Barbro Beijer, Keith Graham, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2009
Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: closing the gap between benefit and toxicity?Inga Buchmann, Ralf G Meyer, Walter Mier, et al.
Protein and Peptide Letters|March 10, 2007
Radiolabeled peptides and proteins in cancer therapyCarmen Wängler, Inga Buchmann, Michael Eisenhut, et al.
Pageof 19